Home LiteratureArticle Details
PMID: 8621783 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

The Journal of clinical investigation ·Vol. 97 ·No. 8 ·1996-04-15 ·Pages 1978-82

Siragy HM, Carey RM

Abstract

The renal effects of angiotensin II(AII) are attributed to AT1 receptors. In contrast, the function of renal AT2 receptors in unknown. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) prostaglandin E2 (PGE2) and cyclic guanosine 3', 5'-monophosphate (cGMP) in response to dietary sodium (Na) depletion alone, or Na depletion or normal Na diet combined with the AT1 receptor blocker, Losartan, the AT2 receptor blocker, PD 123319 (PD), or angiotensin II, individually or combined in conscious rats. Na depletion significantly increased PGE2 and cGMP. During Na depletion, Losartan decreased PGE2 and did not change cGMP. In contrast, PD significantly increased PGE2 and decreased cGMP. Combined administration of Losartan and PD decreased PGE2 and cGMP. During normal Na diet, RIF PGE2 and cGMP increased in response to angiotensin II. Neither Losartan nor PD, individually or combined, changed RIF PGE2 or cGMP. Combined administration of angiotensin II and Losartan or PD produced a significant decrease in response of PGE2 and cGMP to angiotensin II, respectively. These data demonstrate that activation of the reninangiotensin system during Na depletion increases renal interstitial PGE2 and cGMP. The AT1 receptor mediates renal production of PGE2. The AT2 receptor mediates cGMP. AT2 blockade potentiates angiotensin-induced PGE2 production at the AT1 receptor.

MeSH Terms
Analysis of Variance Angiotensin II/pharmacology Animals Biphenyl Compounds/pharmacology Cyclic AMP/metabolism Dinoprostone/metabolism Extracellular Space/drug effects,metabolism Female Imidazoles/pharmacology Kidney/drug effects,metabolism Kinetics Losartan Microdialysis Pyridines/pharmacology Rats Rats, Sprague-Dawley Receptors, Angiotensin/drug effects,physiology Reference Values Sodium, Dietary/pharmacology Tetrazoles/pharmacology Time Factors
Chemicals
Biphenyl Compounds Imidazoles Pyridines Receptors, Angiotensin Sodium, Dietary Tetrazoles Angiotensin II PD 123319 Cyclic AMP Losartan Dinoprostone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Siragy H M
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA.
Carey R M
References (22)
22 references, click to expand
  1. In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney.
    Ren Physiol Biochem. 1992 Sep-Oct;15(5):231-9 PMID: 1279763
  2. Angiotensin II receptor subtypes in cultured rat renal mesangial cells.
    Am J Physiol. 1992 Sep;263(3 Pt 2):F411-6 PMID: 1415569
  3. Localization and properties of angiotensin II receptors in rat kidney.
    Kidney Int Suppl. 1993 Jul;42:S40-6 PMID: 8361127
  4. Stimulation of renal interstitial bradykinin by sodium depletion.
    Am J Hypertens. 1993 Oct;6(10):863-6 PMID: 8267942
  5. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
    Eur J Pharmacol. 1993 Nov 2;249(1):85-93 PMID: 8282023
  6. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation.
    J Clin Invest. 1994 May;93(5):1940-7 PMID: 7514189
  7. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake.
    Hypertension. 1994 Jun;23(6 Pt 2):1068-70 PMID: 8206596
  8. Cyclic GMP and regulation of cyclic nucleotide hydrolysis.
    Adv Pharmacol. 1994;26:87-114 PMID: 8038108
  9. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats.
    J Clin Invest. 1995 Mar;95(3):1394-7 PMID: 7883985
  10. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition.
    Hypertension. 1995 May;25(5):1021-4 PMID: 7737709
  11. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
    Br J Pharmacol. 1993 May;109(1):148-56 PMID: 8495237
  12. Plasma renin activity during pentobarbital anesthesia and graded hemorrhage in dogs.
    Am J Physiol. 1975 Oct;229(4):1098-101 PMID: 1238024
  13. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.
    J Cyclic Nucleotide Res. 1975;1(4):207-18 PMID: 177461
  14. Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins.
    Prostaglandins. 1977 Jun;13(6):1113-25 PMID: 887800
  15. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.
    J Clin Invest. 1981 Feb;67(2):540-6 PMID: 6257764
  16. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.
    Prostaglandins. 1980 Nov;20(5):947-57 PMID: 6258197
  17. Cyclic AMP and the regulation of prostaglandin production by macrophages.
    Biochem Biophys Res Commun. 1983 Jul 18;114(1):248-54 PMID: 6309167
  18. Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics.
    Kidney Int. 1984 Jun;25(6):857-68 PMID: 6088885
  19. Subclasses of angiotensin II binding sites and their functional significance.
    Mol Pharmacol. 1990 Sep;38(3):370-7 PMID: 2402226
  20. Nitric oxide: physiology, pathophysiology, and pharmacology.
    Pharmacol Rev. 1991 Jun;43(2):109-42 PMID: 1852778
  21. Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat.
    Am J Physiol. 1992 Mar;262(3 Pt 2):F417-24 PMID: 1313644
  22. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
    J Pharmacol Exp Ther. 1992 Sep;262(3):1154-60 PMID: 1527720
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1996-04-15
Pages
1978-82
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC507268
Subset
IM
Grants
NHLBI NIH HHS · HL-476629 · United States
NHLBI NIH HHS · HL-49575 · United States
NHLBI NIH HHS · K04 HL-02006 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]